lifestyle.thedishh.com

Author: Hope Medicine Inc.

Hope Medicine Announces First Patient Dosed in the Phase III Clinical Trial for Endometriosis

March 25, 2026
Hope Medicine Inc.’s HMI-115 Received U.S. FDA Fast Track Designation, Accelerating Global Development

December 11, 2025
HMI-115, a Potential First-in-Class Treatment for Endometriosis, Published Proof-of-Concept Phase II Clinical Trial Results in The Lancet Obstetrics, Gynaecology, & Women’s Health

November 11, 2025